They further confirmed the possible functional relevance of FSCN1 expression in the development of Triple-Negative Breast Cancer (TNBC) because it was substantially higher in TNBC than in the non-TNBC subtype. Here, FSCN1 is linked to triple-negative breast carcinoma.